Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Honeywell enabled services powered by Forge to help industrial customers ensure control system health, performance and compliance
Honeywell today announced its Enabled Services program powered by Honeywell Forge, a new automation lifecycle […]
FDA approves first extended-release, injectable drug regimen for adults living with HIV
The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as […]
NHSX: AI at the Forefront of Efforts to Treat Coronavirus Patients
NHSX, a unit tasked with driving the digital transformation of care in the NHS, has […]
Honeywell expands life sciences and software capabilities through acquisition of Sparta Systems
Honeywell today announced it has agreed to acquire privately held Sparta Systems for $1.3 billion in […]
FDA statement on following the authorized dosing schedules for COVID-19 vaccines
Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 […]
Angelini Pharma acquires Arvelle Therapeutics
Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini […]
Fujifilm invests $40 Million in New State-of-the-Art Viral Vector Facility
Fujifilm Corporation will make a major capital investment of approximately 4 billion yen ($40 million) […]
Panxora leads $1.5m USD medical blockchain token fundraising
Panxora Digital Ventures, part of the Panxora Group announces it will lead token investment syndicate […]
Pill Connect secures £0.5m to take electronic smart pill bottle that monitors patient adherence to commercial launch
Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round with the […]
Moderna announces FDA Authorization of Moderna COVID-19 vaccine in U.S.
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more